India · Delayed Price · Currency is INR Coral Laboratories Company Description
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.
The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products.
It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral.
In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products.
Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1994 |
| Industry | Pharmaceutical Preparations |
| Employees | 197 |
| CEO | Girish Dhameja |
Contact Details
Address: #3B, Patanwala Industrial Estate Mumbai, Gujarat 400086 India | |
| Phone | 91 22 2500 5245 |
| Website | corallab.com |
Stock Details
| Ticker Symbol | 524506 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Girish Dhameja | Chief Executive Officer |
| Sushma Kadkade | Chief Financial Officer |